当前位置: 首页 > 期刊 > 《中国现代医生》 > 20209
编号:13493812
伏硫西汀对抑郁症疗效、认知功能和BDNF影响的研究进展(6)
http://www.100md.com 2020年3月25日 《中国现代医生》 20209
     [26] Smith J,Browning M,Conen S,et al. Vortioxetine reduces BOLD signal during performance of the N-back working memory task:A randomised neuroimaging trial in remitted depressed patients and healthy controls[J]. Mol Psychiatry,2018,23(5):1127-1133.

    [27] Levada OA,Troyan AS. Cognitive-functional relationships in major depressive disorder:Crucial data from a Ukrainian open-label study of vortioxetine versus escitalopram[J]. J Affect Disord,2019,250:114-122.

    [28] Lee Y,Rosenblat JD,Lee J,et al. Efficacy of antidepressants on measures of workplace functioning in major depressive disorder:A systematic review[J].J Affect Disord,2018,227:406-415.

    [29] Sagud M,Nikolac Perkovic M,Vuksan-Cusa B,et al. A prospective,longitudinal study of platelet serotonin and plasma brain-derived neurotrophic factor concentrations in major depression:Effects of vortioxetine treatment[J].Psychopharmacology(Berl),2016,233(17):3259-3267.

    [30] Chen F,Danladi J,Ardalan M,et al. A critical role of mitochondria in BDNF-Associated synaptic plasticity After one-week vortioxetine treatment[J]. Int J Neuropsychopharmacol,2018,21(6):603-615.

    (收稿日期:2019-12-31), 百拇医药(矫健萍 胡健波 黄满丽)
上一页1 2 3 4 5 6